SciY and Allchemy announce strategic distribution agreement

FHS
August 28, 2024
10:43 am

SciY is proud to announce a strategic distribution agreement with Allchemy, a pioneer in Artificial Intelligence (AI) driven drug discovery, co-founded by renowned experts Dr. Sara Szymkuć and Prof. Bartosz Grzybowski.

NIH funds study on psychedelics’ potential to treat methamphetamine addiction

John McCorvy, PhD, Assistant Professor in the Department of Cell Biology, Neurobiology, and Anatomy at the Medical College of Wisconsin (MCW); Adam Halberstadt, PhD, Professor

August 27, 2024

It takes GUTS to be BOLD: A look at the new biotech tickers

As the public markets heat up in biotech, industry insiders expect a small drumbeat of IPOs later this spring, and that means a new set

March 16, 2024

Roche’s Columvi receives marketing approval in Europe – Pharmaceutical Technology

Columvi is a CD20xCD3 T-cell engaging bispecific antibody designed to treat R/R DLBCL and is given for a fixed time, a maximum of 12 cycles.

July 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.